je.st
news
Tag: analyses
SITA analyses Chinas use of technology for passenger travel
2016-03-14 01:00:00| Airport Technology
An analysis by global IT provider SITA has revealed that Chinese airports and airlines are investing more on innovation than other countries.
Tags: technology
travel
analyses
passenger
Ingnieur Analyses Mcanique hf
2016-01-26 11:04:50| Space-careers.com Jobs RSS
Airbus Defence and Space est une division du groupe Airbus, ne du regroupement des activits de Cassidian, Astrium et Airbus Military. Cette nouvelle division est le numro un europen de lindustrie spatiale et de la dfense, le numro deux mondial de lindustrie spatiale et fait partie des dix premires entreprises mondiales du secteur de la dfense. Elle ralise un chiffre daffaires annuel denviron 14 milliards deuros avec un effectif de quelque 40 000 employs. Deux postes dIngnieur Justification Etages Lanceurs hf viennent de souvrir au sein dAirbus Defence Space sur son site de SaintMdardenJalles Bordeaux. Au cur des projets de dveloppement des tages de lanceurs et des moyens dintgration au sol, vous serez responsable des tudes mcaniques relatives la conception et la justification des structures principales de vhicules spatiaux. Dcouvrez lintgralit de cette opportunit en suivant le lien! Nous recherchons des candidates ayant lexprience et les comptences suivantes o Titulaire dun diplme dingnieur en gnie mcanique etou arospatial, o A minima 2 annes dexprience sur des missions similaires, o Bonnes connaissances en conception de structures, o Une connaissance de SAMCEF serait un plus, o Autonomie, rigueur et mthode, o Solides capacits de communication, o Esprit danalyse et de synthse, o Niveau de ngociation en franais et niveau intermdiaire en anglais. Merci de bien vouloir postuler en ligne, sur notre site Carrires www.jobs.airbusgroup.com en joignant votre C.V. En soumettant votre CV ou votre candidature, vous consentez Airbus Group lutilisation et lenregistrement dinformations vous concernant des fins de suivi relatif votre candidature ou futur emploi. Ces informations resteront lusage exclusif dAirbus Group. Airbus Group sengage pour la Diversit. Nous encourageons toutes les candidatures indpendamment de lorigine sociale et culturelle, de lge, du genre, du handicap, de lorientation sexuelle ou des croyances religieuses. Airbus Group Recruitment Centre To apply click here
Tags: analyses
mcanique
ingnieur
New Analyses from the IMPROVE-IT Study with VYTORIN (ezetimibe and simvastatin)
2015-09-01 15:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Further Analyses on the Long-Term Safety and Efficacy of VYTORIN from the IMPROVE-IT Study Presented at the European Society of Cardiology (ESC) Meeting KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD in the United States and Canada, today announced results from new analyses from the IMPROVE-IT study. IMPROVE-IT presents us with the opportunity to look at cardiovascular outcomes data for patients treated with the combination of simvastatin and ezetimibe (VYTORIN) and allows us to look at the important aspect of long-term safety and efficacy under controlled conditions, said Dr. Michael A. Blazing, Duke Department of Medicine. Language: English Contact: For MerckMedia:Pamela Eisele, 267-305-3558orMichael Close, 267-305-1211orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
analyses
simvastatin
vytorin
New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA (sitagliptin) Will Be Presented at the European Society of Cardiology Congress
2015-08-20 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Additional Real-World Analyses from DYSIS and DYSIS II Assessing the Treatment of Dyslipidemia to be Presented KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that new analyses from the investigational IMPROVE-IT (IMProved Reduction of Outcomes: VYTORIN Efficacy International Trial) study of VYTORIN (ezetimibe and simvastatin), the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial of JANUVIA (sitagliptin), and real-world data from the Dyslipidemia International Study (DYSIS I and DYSIS II) will be presented at the upcoming European Socie Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orKim Hamilton, 908-391-0131orInvestor:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Core Lab Acquires Sanchez Technologies; Company Increases Reservoir Fluids Technology; Core Worldwide Leader in High Pressure Mercury-Free PVT Analyses
2015-06-29 12:31:08| Industrial Newsroom - All News for Today
AMSTERDAM Core Laboratories N.V. (NYSE: "CLB US")(Euronext Amsterdam: "CLB NA") announced the all cash acquisition of Sanchez Technologies, based in Viarmes, France. Sanchez is a designer and manufacturer of cutting edge reservoir conditions pressure-volume-temperature ("PVT") equipment and instrumentation. These...
Tags: high
company
technology
core